Trial Details

COMPLETED
Basic Information
Clinical ID c916
Identifier NCT05816681
Trial Title Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Diarrhea
Interventions DRUG: DWJ1230|DRUG: DWB2001
Participant Information
Sponsor Daewoong Pharmaceutical Co. LTD.
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2022-08-22
Primary Completion Date 2023-02-06
Completion Date 2023-04-10